BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

785 related articles for article (PubMed ID: 18667698)

  • 21. Fetal hemoglobin in sickle cell anemia: molecular characterization of the unusually high fetal hemoglobin phenotype in African Americans.
    Akinsheye I; Solovieff N; Ngo D; Malek A; Sebastiani P; Steinberg MH; Chui DH
    Am J Hematol; 2012 Feb; 87(2):217-9. PubMed ID: 22139998
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Original Research: A case-control genome-wide association study identifies genetic modifiers of fetal hemoglobin in sickle cell disease.
    Liu L; Pertsemlidis A; Ding LH; Story MD; Steinberg MH; Sebastiani P; Hoppe C; Ballas SK; Pace BS
    Exp Biol Med (Maywood); 2016 Apr; 241(7):706-18. PubMed ID: 27022141
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetics of fetal hemoglobin in tribal Indian patients with sickle cell anemia.
    Bhanushali AA; Patra PK; Pradhan S; Khanka SS; Singh S; Das BR
    Transl Res; 2015 Jun; 165(6):696-703. PubMed ID: 25651163
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Meta-analysis of 2040 sickle cell anemia patients: BCL11A and HBS1L-MYB are the major modifiers of HbF in African Americans.
    Bae HT; Baldwin CT; Sebastiani P; Telen MJ; Ashley-Koch A; Garrett M; Hooper WC; Bean CJ; Debaun MR; Arking DE; Bhatnagar P; Casella JF; Keefer JR; Barron-Casella E; Gordeuk V; Kato GJ; Minniti C; Taylor J; Campbell A; Luchtman-Jones L; Hoppe C; Gladwin MT; Zhang Y; Steinberg MH
    Blood; 2012 Aug; 120(9):1961-2. PubMed ID: 22936743
    [No Abstract]   [Full Text] [Related]  

  • 25. Genetic Modifiers of Fetal Haemoglobin in Sickle Cell Disease.
    Menzel S; Thein SL
    Mol Diagn Ther; 2019 Apr; 23(2):235-244. PubMed ID: 30478714
    [TBL] [Abstract][Full Text] [Related]  

  • 26. rs11886868 and rs4671393 of BCL11A associated with HbF level variation and modulate clinical events among sickle cell anemia patients.
    Chaouch L; Moumni I; Ouragini H; Darragi I; Kalai M; Chaouachi D; Boudrigua I; Hafsia R; Abbes S
    Hematology; 2016 Aug; 21(7):425-9. PubMed ID: 27077760
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A survey of genetic fetal-haemoglobin modifiers in Nigerian patients with sickle cell anaemia.
    Adeyemo TA; Ojewunmi OO; Oyetunji IA; Rooks H; Rees DC; Akinsulie AO; Akanmu AS; Thein SL; Menzel S
    PLoS One; 2018; 13(6):e0197927. PubMed ID: 29879141
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Existence of HbF Enhancer Haplotypes at
    Cyrus C; Vatte C; Borgio JF; Al-Rubaish A; Chathoth S; Nasserullah ZA; Jarrash SA; Sulaiman A; Qutub H; Alsaleem H; Alzahrani AJ; Steinberg MH; Ali AK
    Biomed Res Int; 2017; 2017():1972429. PubMed ID: 28280727
    [No Abstract]   [Full Text] [Related]  

  • 29. Genetic variants at HbF-modifier loci moderate anemia and leukocytosis in sickle cell disease in Tanzania.
    Mtatiro SN; Makani J; Mmbando B; Thein SL; Menzel S; Cox SE
    Am J Hematol; 2015 Jan; 90(1):E1-4. PubMed ID: 25263325
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of BCL11A and HMIP-2 polymorphisms on endogenous and hydroxyurea induced levels of fetal hemoglobin in sickle cell anemia patients from southern Brazil.
    Friedrisch JR; Sheehan V; Flanagan JM; Baldan A; Summarell CC; Bittar CM; Friedrisch BK; Wilke II; Ribeiro CB; Daudt LE; da Rocha Silla LM
    Blood Cells Mol Dis; 2016 Nov; 62():32-37. PubMed ID: 27838552
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of BCL11A, HBS1L-MYB, HBBP1 single nucleotide polymorphisms and the HBG2 XmnI polymorphism On Hb F levels.
    Roy P; Bhattacharya G; Mandal A; Dasgupta UB; Banerjee D; Chandra S; Das M
    Hemoglobin; 2012; 36(6):592-9. PubMed ID: 23094636
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fetal hemoglobin modulates neurocognitive performance in sickle cell anemia
    Heitzer AM; Longoria J; Rampersaud E; Rashkin SR; Estepp JH; Okhomina VI; Wang WC; Raches D; Potter B; Steinberg MH; King AA; Kang G; Hankins JS
    Curr Res Transl Med; 2022 Jul; 70(3):103335. PubMed ID: 35303690
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fetal hemoglobin-boosting haplotypes of BCL11A gene and HBS1L-MYB intergenic region in the prediction of clinical and hematological outcomes in a cohort of children with sickle cell anemia.
    Sales RR; Nogueira BL; Belisário AR; Faria G; Mendes F; Viana MB; Luizon MR
    J Hum Genet; 2022 Dec; 67(12):701-709. PubMed ID: 36167770
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic association of fetal-hemoglobin levels in individuals with sickle cell disease in Tanzania maps to conserved regulatory elements within the MYB core enhancer.
    Mtatiro SN; Mgaya J; Singh T; Mariki H; Rooks H; Soka D; Mmbando B; Thein SL; Barrett JC; Makani J; Cox SE; Menzel S
    BMC Med Genet; 2015 Feb; 16():4. PubMed ID: 25928412
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fine-mapping at three loci known to affect fetal hemoglobin levels explains additional genetic variation.
    Galarneau G; Palmer CD; Sankaran VG; Orkin SH; Hirschhorn JN; Lettre G
    Nat Genet; 2010 Dec; 42(12):1049-51. PubMed ID: 21057501
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identifying genetic variants and pathways associated with extreme levels of fetal hemoglobin in sickle cell disease in Tanzania.
    Nkya S; Mwita L; Mgaya J; Kumburu H; van Zwetselaar M; Menzel S; Mazandu GK; Sangeda R; Chimusa E; Makani J
    BMC Med Genet; 2020 Jun; 21(1):125. PubMed ID: 32503527
    [TBL] [Abstract][Full Text] [Related]  

  • 37. BCL11A enhancer haplotypes and fetal hemoglobin in sickle cell anemia.
    Sebastiani P; Farrell JJ; Alsultan A; Wang S; Edward HL; Shappell H; Bae H; Milton JN; Baldwin CT; Al-Rubaish AM; Naserullah Z; Al-Muhanna F; Alsuliman A; Patra PK; Farrer LA; Ngo D; Vathipadiekal V; Chui DH; Al-Ali AK; Steinberg MH
    Blood Cells Mol Dis; 2015 Mar; 54(3):224-30. PubMed ID: 25703683
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Polymorphism at BCL11A compared to HBS1L-MYB loci explains less of the variance in HbF in patients with sickle cell disease in Cameroon.
    Bitoungui VJ; Ngogang J; Wonkam A
    Blood Cells Mol Dis; 2015 Mar; 54(3):268-9. PubMed ID: 25488618
    [No Abstract]   [Full Text] [Related]  

  • 39. BCL11A is a major HbF quantitative trait locus in three different populations with beta-hemoglobinopathies.
    Sedgewick AE; Timofeev N; Sebastiani P; So JCC; Ma ESK; Chan LC; Fucharoen G; Fucharoen S; Barbosa CG; Vardarajan BN; Farrer LA; Baldwin CT; Steinberg MH; Chui DHK
    Blood Cells Mol Dis; 2008; 41(3):255-258. PubMed ID: 18691915
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Unique Polymorphisms at
    Akbulut-Jeradi N; Fernandez MJ; Al Khaldi R; Sukumaran J; Adekile A
    J Pers Med; 2021 Jun; 11(6):. PubMed ID: 34204365
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 40.